Select Biotechnolgy PortFBIOX
13F holders, Q2 2026 (June 30)2holders −1
0new positions
0sold out
$28.69avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Select Biotechnolgy Port (FBIOX) in their 13F filings, down 1 from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Financial Gravity Companies, Inc. ($15K) and Coston, McIsaac & Partners ($2K).
- Company
- Select Biotechnolgy Port
- Filed as
- FIDELITY SELECT BIOTECHNOLOGY (Q2 2026)
- CUSIP
- 316390772
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 3 shares bought, net +3 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Financial Gravity Companies, Inc. | 0.00% | — | 508 | $15K |
| Coston, McIsaac & Partners | 0.00% | Add +4.1% | 76 | $2K |
"% of holder's portfolio" is FBIOX's weight in each manager's 13F, not the share of Select Biotechnolgy Port the manager owns.